COVID-19 Updates Newsletter
Determining Your Employee Vaccination Strategy
Acheson Group
January 29 2021
COVID-19
Key Points Points: Today, we discuss Determining Your Employee Vaccination Strategy in the Recommendations for Industry. The first two cases…
TAG U.S. Risk Matrix and Masking
Acheson Group
January 27 2021
COVID-19
Key Points: In today’s Recommendations for industry, we discuss this week’s Risk Matrices and address the issue of wearing two…
TAG COVID-19 Newsletter Archive
This page is updated daily and contains Key Points to note from
TAG's COVID-19 daily newsletter and updates.
January 25, 2021
-
In today’s Recommendations for Industry, we discuss the new administration’s federal strategy for COVID-19 worker protections.
-
On Thursday, The White House released a new Executive Order on Protecting Worker Health and Safety, which outlines actions the federal government must take to reduce the risk that workers may contract COVID-19 in the workplace. Actions include “partnering with state and local governments to better protect public employees; enforcing worker health and safety requirements; and pushing for additional resources to help employers protect employees.”
-
CDC has tweaked recommendations for the second dose of COVID-19 vaccinations (without data) to note that in extreme circumstances, the second dose can be another vaccine. TAG encourages employers to work with public health authorities to find a consistent and reliable source of vaccines so that this practice isn’t necessary.
-
Bharat Biotech’s BBV152 COVID-19 Phase 1 vaccine data “shows it is safe and immune-producing.”
-
A recent Kaiser Family Foundation poll shows that despite the push to get people vaccinated, 6 of 10 U.S. adults don’t know when they’ll get the COVID-19 vaccine; while 55% do not know where they will be able to receive one. However, the public is generally optimistic about the COVID-19 vaccination efforts. Read more of the report here.
-
Like other countries, the U.S., in order to slow the spread of the new COVID-19 strains, will soon place non-U.S. citizen travel restrictions to and from South Africa.
January 22, 2021
-
-
In today’s Recommendations for Industry, we explore President Biden’s new Federal Strategy – and a new TAG Vaccine Manual!
-
United State’s President Joe Biden and the incoming administration has released the “National Strategy for The COVID-19 Response and Pandemic Preparedness”
-
President Biden is also encouraging “masking up” to reduce spread so that more businesses can be open. Masks will be required in airports, trains, intercity busses, etc. Additionally, the new Executive Order requires international travelers to show proof of having a negative COVID-19 test before coming to the U.S.
-
NPR reports that both the National Institutes of Health and the Infectious Diseases Society of America continue to update COVID-19 treatment guidelines, essentially giving a “scorecard on COVID-19 drugs”.
-
On Thursday, there was a fire at an Indian facility producing Astrazeneca vaccines.
-
Nature reports that there is growing evidence “that some coronavirus variants could evade immune responses triggered by vaccines and previous infection”. However, this is still under investigation and “the picture is murky” as the results do not yet indicate the full importance.
-
From the emerging data, the B1117 variants “shouldn’t make a difference to the vaccine’s effectiveness but could as antibody levels wane over time.”
-
There may be a dampened response to the 501Y.V2 variant.
-
-
January 20, 2021
-
-
-
In today’s Recommendations for Industry, we explore this week’s U.S. 50-State Risk Matrix some encouraging downward trends in case rates and transmission of the COVID-19 virus.
-
It is now believed that the B117 COVID-19 variant likely has been circulating in California and Florida since mid-November. There are currently 122 confirmed cases in 20 states.
-
In addition to TAG’s Vaccine Q&A, the New England Journal of Medicine has its own COVID-19 vaccine FAQ.
-
Although travel restrictions were set to be lifted by outgoing U.S. President Trump for 26 countries in the Schengen zone and Brazil, starting January 26th, incoming President Joe Biden is expected to block this order, due to the increasing rise in COVID-19 variants and coronavirus spread.
-
Due to manufacturing disruptions in Belgium, Pfizer has alerted Canada that the country would not be receiving any COVID-19 vaccines next week.
-
Hospital beds in intensive care units across various counties around the U.S. are running out of beds. It is important to continue your preventive measures so that you may protect
-
Kaiser Health reports that Black Americans are less likely to (and currently) not being vaccinated at the same rates as whites; due to lack of access and anti-vaccine sentiment.
-
Moderna is currently investigating some “higher than usual number of possible allergic reactions” from a specific clinic in San Diego, CA. Early indications suggest that these reactions may be associated with a specific lot of vaccine.
-
-
January 18, 2021
-
-
-
In today’s Recommendations for Industry, we discuss the potential that the new variants may upend the current stable period we see with COVID-19 cases. Read more.
-
The COVID-19 death toll has risen over 2 million worldwide; this marks a new milestone in this pandemic.
-
In the U.S., the B117 variant of COVID-19 is expected to become the dominant COVID-19 strain in the upcoming months (by March 2021). It is imperative that despite receiving the vaccine, everyone continues to practice preventive measures, including mask-wearing, hand washing, and social distancing
-
-
January 15, 2021
-
In today’s Recommendations for Industry, we explore the latest on the COVID-19 vaccine and complexities and business decisions surrounding it. Read more.
-
The CDC has released some information on the types of symptoms to expect after receiving a vaccine.
-
The NYT reports that at least 28 states have begun vaccinating individuals >65 years old; at a federal level, there is a push for vaccinating all individuals >65 years old. Read more on CIDRAP
-
A new systematic review and meta-analysis has been released that studies “The Sensitivity and Costs of Testing for SARS-CoV-2 Infection with Saliva Versus Nasopharyngeal Swabs.”
-
A recent study from China exploring the “6-month consequences of COVID-19 in patients discharged from hospital: a cohort study” has found that “COVID-19 survivors were mainly troubled with fatigue or muscle weakness, sleep difficulties, and anxiety or depression. Patients who were more severely ill during their hospital stay had more severe impaired pulmonary diffusion capacities and abnormal chest imaging manifestations”
-
The CDC’s most recent MMWR found that while stringent restrictions may have come with high social and economic costs, “European countries that implemented more stringent mitigation policies earlier in their outbreak response tended to report fewer COVID-19 deaths through the end of June 2020. These countries might have saved several thousand lives relative to countries that implemented similar policies, but later.”
January 13, 2021
-
In today’s Recommendations for Industry, we explore this week’s U.S. 50 State Risk Matrix and the apparent calm before the storm
-
On Tuesday (January 12, 2021), the U.S. CDC has issued an order requiring that all air passengers arriving to the US from a foreign country be tested no more than 3 days before their flight departs and provide proof of the negative result or documentation of having recovered from COVID-19 to the airline before boarding the flight. This order will go into effect on Tuesday, January 26, 2021.
-
Similar to TAG’s FAQs, NPR breaks down why it is still necessary to wear masks and avoid crowds even after getting the COVID-19 vaccine.
-
The U.S.’s Operation Warp Speed has announced a pivot in its COVID-19 vaccine strategy to vaccinate all those 65 and over as quickly as possible with the vaccines that are available. Read more on CIDRAP.
-
A best practice of keeping COVID-19 out of your home is to improve the ventilation (air flow) and bring in fresh air, especially if you are having visitors. This extra step, on top of staying 6 feet apart and wearing masks, can decrease your risk of getting/spreading COVID-19. Improving ventilation may include, opening windows, using air filters, and turning on fans – all actions that can clear the air and move the particles out of the space you’re in.
-
You can also use a window exhaust fan or place a fan as close as possible to an open door or window, blowing outwards.
-
If you want a portable air cleaner, consider using a high-efficiency particular air (HEPA) cleaner sized for the room(s) you are airing out.
-
Read more tips from the CDC, including how to use ceiling fans, vent bathrooms, etc.
-
-
Beware of black market COVID-19 vaccines. As we mentioned, COVID-19 vaccines are only being administered at approved locations.
January 11, 2021
-
In today’s Recommendations for Industry, we discuss
-
The FDA has issued an alert that some of the genetic COVID-19 variants may impact the results and lead to false negatives with a few COVID-19 molecular tests (e.g. Accula SARS-Cov-2 Test; TaqPath COVID-19 Combo Kit; Linea COVID-19 Assay Kit).
-
Last Thursday, the U.S. hit a new record of single-day deaths from COVID-19 with over 4,085 deaths. Although the vaccine is still being distributed, it is still important to maintain social distancing, wear a mask, continue washing hands, and practice other preventive measures to keep everyone safe.
-
In Los Angeles County, California, 1 in 5 COVID-19 tests are positive, indicating that the virus is still spreading at an incredible rate.
-
FDA has issued a warning to beware of fraudulent tests, vaccines, and treatments. Be wary of unofficial COVID-19 vaccines and unscrupulous individuals who may be selling or administering the vaccine. Currently, vaccines are being distributed and administered through health departments, hospitals, pharmacies, and other valid medical or pharmaceutical facilities. Do not take a vaccine that is offered outside of locations listed above. If you have questions about the appropriateness of a vaccination site, reach out to your local or state health department.
-
Japan has identified a new COVID-19 variant (B.1.1.248 strain with 12 mutations in the spike protein) that has similar mutations as those seen currently in the South Africa and UK variants. However, more studies must still be done to understand how this new variant may affect disease transmissibility or severity.
January 08, 2021
-
In today’s Recommendations for Industry, we discuss how businesses can determine the COVID-19 vaccination priorities and directives of the states in which they operate. Read more.
-
We also are continuing to populate the TAG Vaccine Q&A page. Today’s questions focus on (a) the efficacy of current tests and (b) managing potentially serious reactions of vaccines.
January 06, 2021
-
In today’s Recommendations for Industry, we discuss TAG’s COVID-19 Risk Matrix Update: January 05, 2021. Read more.
-
A recent study published in JAMA and reported by CIDRAP finds that 14.3% of the US population had antibodies against COVID-19 by November 2020; implying that more people than reported have been infected. This tracks with the discussion that there may be a lot of COVID-19 underreporting. Additionally, there is evidence that about 35% of COVID-19 related deaths have not been reported.
-
In its weekly situational report, the WHO has found that the UK COVID-19 Variant (also known as the B.1.1.7 variant) has been found in 40 other WHO-involved countries. The South African COVID-19 Variant (501Y.V2) has been detected in six other countries.
-
More European countries are announcing tighter restrictions and lockdowns.
-
-
There is increasing evidence that patients with severe COVID-19 symptoms (post-hospitalization, etc.) have also developed symptoms like those associated with brain injury and other neurological disorders. NPR has summarized the studies.
January 04, 2021
-
In today’s Recommendations for Industry, we discuss the new COVID-19 variants and what their spread means to the U.S. Read more.
-
The FDA has published a new toolkit to communicate hand sanitizer safety & use during COVID-19 in both English and Spanish.
-
The FDA also has a new COVID-19 Communication Toolkits webpage that provides links to all FDA toolkits on COVID-19 topics to help everyone communicate accurate and timely information to patients, the public, and health care professionals.
December 30, 2020
-
In today’s Recommendations for Industry, we discuss TAG’s COVID-19 Risk Matrix Update: December 30, 2020. Read more.
-
To answer your questions about the vaccine, TAG has developed a new COVID-19 Vaccine FAQ webpage. We will continue to update the FAQs both in our COVID newsletter and on that webpage
December 28, 2020
-
In today’s Recommendations for Industry, we discuss questions being asked about the COVID-19 vaccine. Read more.
-
There continues to be a media focus on the new strain of COVID found in the UK, other parts of Europe, Japan, Canada, and likely the U.S. as well. So far, there is no indication that the strain causes any worse disease, although it does seem more infectious. While there is no need to further change behavior, it is critical that all COVID-19 protective behaviors be continued.
-
To answer your questions about the vaccine, TAG has developed a new COVID-19 Vaccine FAQ webpage. We will continue to update the FAQs both in our COVID newsletter and on that webpage
December 23, 2020
-
In today’s Recommendations for Industry, we discuss this week’s matrices – and some behavioral tendencies that are having an impact.
-
With some vaccine recipients who had no previous allergic reactions having reactions to the vaccine, a study published in Science magazine is postulating that the compound polyethylene glycol (PEG) in the packaging of the messenger RNA (mRNA) that forms the vaccine’s main ingredient may be putting a small number of people who were previously exposed to PEG and developed high levels of antibodies against PEG, at risk of an anaphylactic reaction to the vaccine. Thus, it is recommended that the vaccine continue to be administered in facilities equipped to handle anaphylaxis.
-
To answer your questions about the vaccine, TAG has developed a new COVID-19 Vaccine FAQ webpage. We will continue to update the FAQs both in our COVID newsletter and on that webpage.
December 21, 2020
-
In today’s Recommendations for Industry, we discuss CDC’s ACIP Phase 1B definitions of frontline essential workers for COVID-19 vaccinations and Europe’s major lockdown over ‘new’ COVID-19 strain.
December 18, 2020
-
In today’s Recommendations for Industry, we discuss answer some COVID-19 FAQs, including (a) what to do if an employee displays COVID-19 symptoms post-vaccine; and (b) is the vaccine safe for pregnant women.
-
The FDA has recommended Moderna’s vaccine for an EUA. If approved, the Moderna vaccine may be ready to distribute starting next week. As discussed in last Friday’s Vaccine Q&A, there are some differences between the Moderna and Pfizer vaccines, including less stringent temperature requirements (-20C (-4F).
-
The EEOC has added a Vaccines section (K) to its COVID-19 FAQ page, which includes discussion on ADA and Title VII issues in relation to mandatory vaccination policies for employers.
-
Today, Dr. David Acheson will be rounding up the year with SafetyChain Software for a final FSMA Friday 2020, “Navigating COVID Complexity in 2021 to Stay Resilient,” to discuss up-to-the-minute facts, the truth about vaccines, ways you can minimize disruption, and what to expect from COVID-19 in the new year. Sign up now!
-
To address skepticism over the vaccine’s safety and show its safety, Vice-President Mike Pence received his COVID-19 vaccine live on TV.
December 16, 2020
-
In today’s Recommendations for Industry, we discuss TAG’s COVID-19 Risk Matrix. Overall, while the rate of COVID-19 in the US has slowed, there has not been much of a decline. TAG recommends that preventive measures be continued and that employers encourage employees to “stay put” and not travel this upcoming holiday season.
-
The FDA is set to meet to discuss the Moderna vaccine. Data submitted by Moderna to the FDA shows the vaccine to be highly effective. Read the report here.
-
This Friday, Drs. David Acheson & Ben Miller will be rounding up the year with SafetyChain Software for a final FSMA Friday 2020, “Navigating COVID Complexity in 2021 to Stay Resilient,” to discuss up-to-the-minute facts, the truth about vaccines, ways you can minimize disruption, and what to expect from COVID-19 in the new year. Sign up now!
-
On Friday, we will answer more vaccine FAQs that we’ve received. To see our previous FAQs, please see our previous Archived posts!
December 14, 2020
-
In today’s Recommendations for Industry, we discuss a new COVID-19 county-level data set for predictive analyses – and address the vaccine question: What does FDA say about the safety of the Pfizer COVID-19 vaccine for those with allergies?
-
On Friday, the FDA issued its first Emergency Use Authorization for Pfizer-BioNTech’s COVID-19 Vaccine to be distributed in the U.S. The vaccine is currently on its way to locations around the world. In many locations in the U.S., the first doses will go to healthcare workers.
-
This upcoming Friday, Drs. David Acheson & Ben Miller will be rounding up the year with SafetyChain Software for a final FSMA Friday 2020, “Navigating COVID Complexity in 2021 to Stay Resilient,” to discuss up-to-the-minute facts, the truth about vaccines, ways you can minimize disruption, and what to expect from COVID-19 in the new year. Sign up now!
-
The CDC will be hosting a “What Every Clinician Should Know about COVID-19 Vaccine Safety” webinar today, Monday, December 14 from 1:00PM – 2:00PM ET, to discuss the safety of the vaccine, including how to enroll people into the vaccine and methods of checking-up on patients, afterward. Register or call-in here.
-
As the distribution of the COVID-19 vaccine is underway, the CDC has released on “What to Expect at Your Vaccine Appointment”.
-
On Sunday, the CDC updated its list of vaccine-related references. Refer to these resources on the CDC’s website.
-
A biotech conference held in February 2020 in Boston, MA, is shown to be tied to more than 300,000 national and international COVID-19 infections, a recent Science article finds.
-
While much of the world’s focus has been on COVID-19, with the food industry incorporating a range of worker protections, beneath this, momentum has built in the realm of food-related litigation. Not only were criminal convictions a focus of the USDA FSIS’s most recent quarterly enforcement report, but class-action lawsuits have continued to be of focus with Stericycle Expert Solutions anticipating lawsuits “to pass 2019’s total.” What lawsuits and actions happened in 2020 and what do they mean for you?
December 11, 2020
-
In today’s Recommendations for Industry, we discuss the FDA’s vaccine advisory committee’s recommendation to provide EAU for the Pfizer COVID-19 vaccine
-
We also begin a regular COVID-19 Vaccine Q&A (below) to answer your questions and keep you updated as we move into the next vaccination phase of the pandemic.
-
December 09, 2020
-
In todays’ Recommendations for Industry, we find, through the Risk Matrix, that overall conditions in the U.S. remain mostly “the same” (as in, things are not going well – case rates are increasing and Test Positive Rates are increasing all across the country).
-
With vaccines being administered in the UK and moving towards approval in the US, TAG will be providing a Weekly Vaccine Update each Friday and is developing a COVID Vaccine FAQ Resource Page at AchesonGroup.com. Keep an eye out for our Friday discussion.
-
As COVID-19 cases in the US top15 million and continue to surge, the CDC put out thoughts on travel related to the upcoming Holiday Travel Season:
-
Travel can increase your chance of spreading and getting COVID-19. Postponing travel and staying home is the best way to protect yourself and others.
-
You and your travel companions (including children) may feel well and not have any symptoms, but you can still spread COVID-19 to family, friends, and community after travel.
-
Don’t travel if you are sick or test positive for COVID-19. Don’t travel with someone who is sick.
-
-
The FDA analysis of the Pfizer-BioNTech COVID-19 Vaccine is briefly discussed in CIDRAP’s update. While minor side effects occurred (i.e. chills and muscle pain), the vaccine’s efficacy is high and the company’s data shows strong protection after the first dose.. The FDA’s Briefing Document is accessible here. The Pfizer vaccine requires a second booster dose 21-days after the first dose.
-
Last week, the FDA authorized the first diagnostic test for use with home-collected patient samples to detect both COVID-19 and flu for Quest Diagnostics RC COVID-19 + Flu RT-PCR Test with a prescription.
-
A recent report, “Take off your mask so I know how much to tip you: Service Workers’ Experience of Health & Harassment During COVID-19” finds that service industry workers have seen an 80% decrease in tips and an over 40% increase in sexual harassment from customers – including male customers asking for female-presenting workers to remove masks to “judge their looks” to determine tip outcome. Additionally, service industry workers are reluctant to enforce social distancing and mask usage, especially towards customers who may give tips.
December 07, 2020
-
In today’s Recommendations for Industry, we provide an overview of vaccines along with status of the current COVID-19 vaccines developed or in development. Read the brief below, then link to the paper for the full story.
-
With vaccines now a top-of-mind focus for the pandemic, TAG will be providing a Weekly Vaccine Update each Friday and is developing a COVID Vaccine FAQ Resource Page at AchesonGroup.com. Keep an eye out for that!
-
-
This week is National Influenza Vaccination Week (December 06 – 12, 2020). Food, beverage, and agricultural industries are all part of the Critical and Essential workforce, to keep our communities running amid #COVID19. Flu vaccination can help keep healthy so you can continue your vital work. It is not too late to get your flu shot! Find a vaccination location near you using Vaccine Finder.
-
The Associated Press reports that this year, Thanksgiving car travel was only 5% less than that of pre-pandemic times (including 2019).
December 04, 2020
-
In today’s Recommendations for Industry, we discuss CDC’s recent updates for quarantining and what these mean to your business.
-
On Wednesday, the US reported its highest one-day COVID-19 death toll, over 2,800 deaths.
-
On Tuesday, the CDC put out thoughts on travel related to the upcoming Holiday Travel Season:
-
Travel can increase your chance of spreading and getting COVID-19. Postponing travel and staying home is the best way to protect yourself and others.
-
You and your travel companions (including children) may feel well and not have any symptoms, but you can still spread COVID-19 to family, friends, and community after travel.
-
Don’t travel if you are sick or test positive for COVID-19. Don’t travel with someone who is sick.
-
-
The University of Minnesota is inviting Minnesota retail/grocery store employees to participate in a research study to determine how many grocery store workers may have been exposed to and developed antibodies to the SARS-CoV-2 virus (the virus that causes COVID-19) by the end of December 2020. Because grocery store workers are essential employees, they may have had some occupational risk of exposure to SARS-CoV-2 because of community spread of the virus. Study participants will have a test kit mailed to their home so they may self-collect a blood sample. The acquired sample will then be mailed to a laboratory for testing. Individual antibody test results will be reported back to participants; results will not be shared with the grocery store. There will be no cost to study participants and return postage will be included in the provided kit. Find out more here.
-
As part of the FDA’s effort to protect consumers, the agency issued a warning letter jointly with the Federal Trade Commission to Avazo-Healthcare, LLC for selling adulterated and misbranded COVID-19 test kits and unapproved drug products with fraudulent COVID-19 claims. In addition to COVID-19 test kits, the company sells CBD products with misleading claims that the products can mitigate, prevent, treat, diagnose, or cure COVID-19. The FDA has also posted the following warning letters for unapproved and misbranded products related to COVID-19: ChromaDex; Innovative Medicine LLC; Red Moon Herbs; Sage Woman Herbs, Ltd. dba Sage Consulting & Apothecary
December 02, 2020
-
In today’s Recommendations for Industry, we discuss this week’s 50-State Risk Matrix. This week, things seem to be getting better with the general trend going down. But this may be due to increased stringency or lack of testing over the holiday. The next 10 days will be very telling on what post-Thanksgiving trends will be like.
-
The CDC has updated its quarantine recommendations to allow for a shortened period for close contacts who show no symptoms. According to the new recommendations released Wednesday, Dec. 2, CDC allows for the following options (as long as specific additional protective criteria are met)
-
Quarantine can end after Day 10 without testing and if no symptoms have been reported during daily monitoring. With this strategy, residual post-quarantine transmission risk is estimated to be about 1% with an upper limit of about 10%.
-
Quarantine can end after Day 7 if a diagnostic specimen tests negative and no symptoms were reported during daily monitoring. With this strategy, the residual post-quarantine transmission risk is estimated to be about 5% with an upper limit of about 12%.
-
-
As of today, the UK is the first country in the world to approve usage of Pfizer’s COVID-19 vaccine. Distribution and implementation are expected to start next week. The UK has ordered 40 million doses of the two-dose vaccine (for 20 million people).
-
On Tuesday, an independent panel that advises the CDC recommended that “residents and employees of nursing homes and similar facilities” will be among the first in the U.S. to receive the COVID-19 vaccine (NYT). Additionally, health care workers and those especially at-risk of exposure are on that list, too. As CIDRAP reports, there won’t be enough vaccine doses to cover everyone in the first set of vaccinations.
-
In Case You Missed It:
-
In Monday’s Recommendations for Industry, we discussed the current COVID-19 pandemic’s third wave. Will recent lessons learned bring about new quarantine or isolation scenarios?
-
A systematic review and meta-analysis in The Lancet found that researchers could not detect live virus beyond day 9 of illness, even with persistently high viral loads. In fact, SARS-CoV-2 viral load in the upper respiratory tract appeared to peak in the first week of illness. This new analysis may cause the US CDC to consider shortening isolation guidelines in coming weeks.
-
Last Wednesday, we discussed a few of the vaccines that hold promise to protect us against COVID-19.
-
The CDC will likely recommend shortening the coronavirus quarantine period from 14-days to less days with a testing-out strategy (NPR). This announcement tracks with our Industry update from last Friday; read TAG’s take here from last week.
-
On Monday, Moderna planned to apply for an EUA through the FDA for its COVID-19 vaccine. Moderna has confirmed that its COVID-19 vaccine has 94% efficacy.
-
While its vaccine has not received an EUA from FDA yet, Pfizer has begun preparing shipments of its COVID-19 vaccine from Belgium to the U.S., in preparation for distribution. This is in addition to those vaccines produced in Kalamazoo, Michigan.
-
Recent CDC studies have found that fewer than 10% of Americans had contracted COVID-19 through September. While there were some wide variances, another CDC study found increasing declines in antibody levels post-infection that may negatively represent the number of previously infected individuals. CIDRAP summarizes these findings here.
-
A recent article provides five recommendations as guideposts to ensure that policies and practices at the federal, state, local, and tribal levels support equity, transparency, accountability, availability, and access to upcoming COVID-19 vaccines
-
In California, the Cal/OSHA Standards Board has proposed a COVID-19-related emergency standard that may take effect soon. Some of the requirements include a written COVID-19 prevention program; notifying potential COVID-19 close-contact exposures within one (1) business day; ensuring physical distancing measures; requiring employers to provide face coverings and ensure their wearing; new return-to-work guidelines; and new testing requirements especially for businesses with multiple outbreaks within their business. Read a summary here.
-
The FDA published a comprehensive new page with answers to frequently asked questions about face masks, surgical masks, and respirators.
-
The University of Massachusetts Amherst’s Reich Lab has put together a COVID-19 Forecasting Hub that, based on the current data, can provide a predictive model of how future cases of COVID-19 may turn in your area. TAG has reached similar conclusions and predictive thoughts.
-
The “COVID-19 Symptoms Comparison Chart” is now downloadable at our COVID-19 Resources page.
-
November 30, 2020
-
In today’s Recommendations for Industry, we discuss the current COVID-19 pandemic’s third wave. Will recent lessons learned bring about new quarantine or isolation scenarios?
-
A systematic review and meta-analysis in The Lancet found that researchers could not detect live virus beyond day 9 of illness, even with persistently high viral loads. In fact, SARS-CoV-2 viral load in the upper respiratory tract appeared to peak in the first week of illness. This new analysis may cause the US CDC to consider shortening isolation guidelines in coming weeks.
-
Today, Moderna plans to apply for an EUA through the FDA for its COVID-19 vaccine. Moderna has confirmed that its COVID-19 vaccine has 94% efficacy.
-
While its vaccine has not received an EUA from FDA yet, Pfizer has begun preparing shipments of its COVID-19 vaccine from Belgium to the U.S., in preparation for distribution. This is in addition to those vaccines produced in Kalamazoo, Michigan.
-
Recent CDC studies have found that , fewer than 10% of Americans had contracted COVID-19 through September. While there was a wide variance between regions and professions, another CDC study found increasing declines in antibody levels post-infection that may negatively represent the number of previously infected individuals. CIDRAP summarizes these findings here.
-
A recent article provides five recommendations as guideposts to ensure that policies and practices at the federal, state, local, and tribal levels support equity, transparency, accountability, availability, and access to upcoming COVID-19 vaccines.
-
In Case You Missed It:
-
Last Wednesday, we discussed a few of the vaccines with promise to protect us against COVID-19 and the U.S. 50-State Risk Matrix as we enter into the holiday season.
-
The CDC will likely recommend shortening the coronavirus quarantine period from 14-days to less days with a testing-out strategy (NPR). This announcement tracks with our Industry update from last Friday; read TAG’s take here from last week.
-
If you are located in California, the Cal/OSHA Standards Board has proposed a COVID-19-related emergency standard that may likely go into effect soon. Some of the requirements in the criteria include a written COVID-19 prevention program; notifying potential COVID-19 close-contact exposures within one (1) business day; ensuring physical distancing measures; requiring employers to provide face coverings and ensure their wearing; new return-to-work guidelines; and new testing requirements especially for businesses with multiple outbreaks within their business. Read a summary here.
-
The FDA published a comprehensive new page with answers to frequently asked questions about face masks, surgical masks, and respirators.
-
The University of Massachusetts Amherst’s Reich Lab has put together a COVID-19 Forecasting Hub that allows, based on the current data, can provide a predictive model of how the future cases and COVID-19 may turn in your area. TAG has reached similar conclusions and predictive thoughts similar to what the Forecasting Hub shows.
-
The “COVID-19 Symptoms Comparison Chart” is now downloadable at our COVID-19 Resources page.
-
November 25, 2020
-
Happy Thanksgiving to our U.S. readers from all of us at TAG to you and yours. We will not have a Friday COVID-19 Newsletter.
-
In today’s Recommendations for Industry, we discuss the three vaccines with great promise to protect us against COVID-19 and the U.S. 50-State Risk Matrix as we enter into the holiday season.
-
The CDC will likely recommend shortening coronavirus quarantine period from 14-days to less days with a testing-out strategy (NPR). This announcement tracks with our Industry update from last Friday, read TAG’s take here from last week.
-
If you are located in California, the Cal/OSHA Standards Board has just adopted a COVID-19-related emergency standard that may likely go into effect by November 29th and will last at least 180 days (6 months). Some of the requirements in the standards include a written COVID-19 prevention program; notifying potential COVID-19 close-contact exposures within one (1) business day; ensuring physical distancing measures; requiring employers to provide face coverings and ensure their wearing; new return-to-work guidelines; and, new testing requirements especially for businesses with multiple outbreaks within their business. Read a summary here.
-
Yesterday, the FDA has published a comprehensive new page with answers to frequently asked questions about face masks, surgical masks, and respirators.
-
The University of Massachusetts Amherst’s Reich Lab has put together a COVID-19 Forecasting Hub that allows, based on the current data, can provide a predictive model of how the future cases and COVID-19 may turn in your area. TAG has reached similar conclusions and predictive thoughts similar to what the Forecasting Hub shows.
-
Hospitalizations from COVID-19 are rising quickly, even though this week is a huge travel week! The CDC recommends that due to to more than 1 million COVID-19 cases being reported in the U.S. over the last 7 days, the safest way to celebrate Thanksgiving is to celebrate at home with the people you live with. This will limit your chances of getting and/or spreading COVID-19 or the flu.
-
In Case You Missed It:
-
With the dramatic rise in cases (that are anticipated to increase even further) pre-holiday season, on Monday’s Recommendations for Industry, we discussed what businesses can do and what to remind employees of to mitigate the potential COVID-19 spread post-Thanksgiving (and during-holiday) season.
-
On Monday, AstraZeneca (and Oxford University) has reported that the late-stage trials of its coronavirus vaccine has up to a 90% efficacy. This vaccine may be cheaper and easier to distribute than the other two promising vaccines (Pfizer and Moderna).
-
Last Friday, we discussed Potential Strategies for Testing and Exiting Quarantine as Increasing COVID-19 Close-Contacts Continue to Impact the Critical Workforce. Read more here.
-
A recent pre-print, titled “Optimal COVID-19 quarantine and testing strategies,” used data and modeled the optimal timing of testing during quarantine to reduce the probability of post-quarantine transmission.
-
The “COVID-19 Symptoms Comparison Chart” is now downloadable at our COVID-19 Resources page.
-
OSHA has released a one-page notice on the most common COVID-19 citations observed, “Lessons Learned: Frequently Cited Standards Related to COVID-19 Inspections”.
-
The FDA has authorized the first COVID-19 test for self-testing at home. TAG has quickly investigated the Lucira COVID-19 All-In-One Test Kit. While the test is currently unavailable, it “will initially only be available on a limited basis in point of care settings and healthcare networks that prescribe the test for patients to use at home”. The anticipated cost of the test is: ~$50.
-
This winter season, protect yourself and your family from fraudulent flu or antiviral products. Like with COVID-19, there are no legally marketed over-the-counter drugs to prevent to prevent, mitigate, treat, or cure the flu. The FDA advises that the flu vaccine is the best prevention against the influenza and its serious complications.
-
The FDA has approved the EUA for administering casirivimab and imdevimab together for the treatment of mild to moderate COVID-19 patients to reduce COVID-19-related hospitalization or emergency room visits. This combination is not authorized for patients who are hospitalized due to COVID-19 or require oxygen therapy due to COVID-19 (as it can lead to worse clinical outcomes).
-
Recent research from Oxford University’s Blavatnik School of Government finds that within the U.S., states that imposed few restrictions now have the worst outbreaks. TAG will discuss this further on Wednesday (and include it in our U.S. Risk Matrix).
-
November 23, 2020
-
With the dramatic rise in cases (that are anticipated to increase even further) pre-holiday season, today’s Recommendations for Industry discusses what businesses can do and what to remind employees of to mitigate the potential COVID-19 spread post-Thanksgiving (and during-holiday) season.
-
Today, AstraZeneca (and Oxford University) has reported that the late-stage trials of its coronavirus vaccine has up to a 90% efficacy. This vaccine may be cheaper and easier to distribute than the other two promising vaccines (Pfizer and Moderna). TAG will discuss these vaccines, availability, and more on Wednesday! Keep an eye out!
-
OSHA has released a one-page notice on the most common COVID-19 citations observed, “Lessons Learned: Frequently Cited Standards Related to COVID-19 Inspections”.
-
Hospitalizations from COVID-19 are rising quickly, even though this week is a huge travel week! The CDC recommends that due to to more than 1 million COVID-19 cases being reported in the U.S. over the last 7 days, the safest way to celebrate Thanksgiving is to celebrate at home with the people you live with. This will limit your chances of getting and/or spreading COVID-19 or the flu.
-
The FDA has approved the EUA for administering casirivimab and imdevimab together for the treatment of mild to moderate COVID-19 patients to reduce COVID-19-related hospitalization or emergency room visits. This combination is not authorized for patients who are hospitalized due to COVID-19 or require oxygen therapy due to COVID-19 (as it can lead to worse clinical outcomes).
-
Recent research from Oxford University’s Blavatnik School of Government finds that within the U.S., states that imposed few restrictions now have the worst outbreaks. TAG will discuss this further on Wednesday (and include it in our U.S. Risk Matrix).
-
Whether caused by a keener focus on sanitation and food safety – or, as postulated by FSN, a diversion of public health professionals to the pandemic or ill people not seeking medical attention and testing in possible food-poisoning cases – 2020 has seen a definite reduction in outbreaks compared to recent years. With the release of the recent CDC MMWR surveillance report of 2016 outbreaks, there are many similarities between outbreaks then and outbreaks in 2020. What can the food industry learn from these studies? How can these studies and trends provide insight into food safety gaps and the future development of applicable prevention and control strategies? Read more on our blog.
-
In Case You Missed It:
-
On Friday, we discussed Potential Strategies for Testing and Exiting Quarantine as Increasing COVID-19 Close-Contacts Continue to Impact the Critical Workforce. Read more here.
-
A recent pre-print, titled “Optimal COVID-19 quarantine and testing strategies,” used data and modeled the optimal timing of testing during quarantine to reduce the probability of post-quarantine transmission.
-
The “COVID-19 Symptoms Comparison Chart” is now downloadable at our COVID-19 Resources page.
-
The FDA has authorized the first COVID-19 test for self-testing at home. TAG has quickly investigated the Lucira COVID-19 All-In-One Test Kit. While the test is currently unavailable, it “will initially only be available on a limited basis in point of care settings and healthcare networks that prescribe the test for patients to use at home”. The anticipated cost of the test is: ~$50.
-
This winter season, protect yourself and your family from fraudulent flu or antiviral products. Like with COVID-19, there are no legally marketed over-the-counter drugs to prevent to prevent, mitigate, treat, or cure the flu. The FDA advises that the flu vaccine is the best prevention against the influenza and its serious complications.
-
November 20, 2020
-
In today’s Recommendations for Industry, we discuss Potential Strategies for Testing and Exiting Quarantine as Increasing COVID-19 Close-Contacts Continue to Impact the Critical Workforce. Read more here.
-
The CDC recommends that due to to more than 1 million COVID-19 cases being reported in the U.S. over the last 7 days, the safest way to celebrate Thanksgiving is to celebrate at home with the people you live with. This will limit your chances of getting and/or spreading COVID-19 or the flu.
-
A recent pre-print, titled “Optimal COVID-19 quarantine and testing strategies,” used data and modeled the optimal timing of testing during quarantine to reduce the probability of post-quarantine transmission.
-
Join our own Dr. Ben Miller, MPH with CIC Health and the University of Minnesota's Genomics Center on a webinar today Friday (November 20) at 12:00 PM E.T. as they discuss COVID-19 testing on campus, including how surveillance testing can help bridge the gap between now and widespread vaccination programs. Register here: https://link.achesongroup.com/0fdb2
-
As a reminder, a mask is not a substitute for social distancing (maintain 6 feet or more from others around you). Masks should still be worn in addition to staying at least 6 feet (2 meters) apart.
-
The “COVID-19 Symptoms Comparison Chart” is now downloadable at our COVID-19 Resources page.
-
The FDA has issued and authorized the first COVID-19 test for self-testing at home. TAG has quickly looked into the Lucira COVID-19 All-In-One Test Kit. While the test is currently unavailable, it “will initially only be available on a limited basis in point of care settings and healthcare networks that prescribe the test for patients to use at home”. The anticipated cost of the test is: ~$50.
-
In Case You Missed It:
-
On Monday, we discussed and answered the question: How Risky is International – and Domestic – Travel Today?
-
On Wednesday, we explored the TAG’s U.S. Risk Matrix. This week, all states except for Hawaii (and D.C.) have moved to into the High or Highest-Risk Quadrants. Twenty-seven (27) states have a TPR greater than 10% and a case rate ≥ 25/100K, indicating that testing may not be adequate to characterize the true severity of outbreaks across the U.S fully.discuss TAG’s 50 State Risk Matrix. Read more about it here.
-
In last Friday’s Recommendations for Industry we explored testing and When and What COVID Tests Facilities Should Conduct.
-
OSHA and the U.S. Department of Labor have issued Guidance Alerting Employers to Frequently Cited Standards Related to COVID-19 Inspections. The most frequently cited standards and requirements for employers to follow include:
-
Providing a medical evaluation before a worker is fit-tested or uses a respirator.
-
Establishing, implementing, and updating a written respiratory protection program with required worksite-specific procedures.
-
Training workers to safely use respirators and/or other PPE in the workplace, and retrain workers about changes in the workplace that might make previous training obsolete.
-
Storing respirators and other PPE properly in a way to protect them from damage, contamination, and, where applicable, deformation of the facepiece and exhalation valve.
-
Keeping required records of work-related fatalities, injuries, and illness.
-
-
OSHA is also providing upated guidance for Holiday Workplace Safety. There is guidance for those in Retail Sales, for Delivery, and for Order Fulfillment.
-
This winter season, protect yourself and your family from fraudulent flu or antiviral products. Like with COVID-19, there are no legally marketed over-the-counter drugs to prevent to prevent, mitigate, treat, or cure the flu. The FDA advises that the flu vaccine is the best prevention against the influenza and its serious complications.
-
Be Antibiotics Aware. November 18 – 24th is Antimicrobial Awareness Week. Antimicrobial resistance (which includes antibiotic resistance) is a significant threat to both human health and sustainable food production. Drug resistance has made infections harder to treat; however, good hygiene can help stop the spread of infection (especially during the COVID-19 pandemic). Find out more about the effects antimicrobial resistance has on food, health, and more.
-
Did you miss the October’s FSMA Friday in which TAG’s own Eric Edmunds discussed DA’s proposed Food Traceability Rule, the affected foods and ingredients on its Food Traceability List (FTL) and the rule’s foundational elements: Critical Tracking Events (CTEs) and Key Data Elements (KDEs), along with other key elements of the rule? Find the main points and recording here.
-
China continues to report the presence of coronavirus on imported food products and packagingof shrimp, fish, beef, and pork. However, guidance from World Health Organization and other organizations continue to indicate that it is highly unlikely that people can contract COVID-19 from food or food packaging. Read the news from Food Safety News.
-
November 16, 2020
-
In today’s Recommendations for Industry, we answer the question: How Risky is International – and Domestic – Travel Today?
-
OSHA and the U.S. Department of Labor have issued Guidance Alerting Employers to Frequently Cited Standards Related to COVID-19 Inspections. The most frequently cited standards and requirements for employers to follow include:
-
Providing a medical evaluation before a worker is fit-tested or uses a respirator.
-
Establishing, implementing, and updating a written respiratory protection program with required worksite-specific procedures.
-
Training workers to safely use respirators and/or other PPE in the workplace, and retrain workers about changes in the workplace that might make previous training obsolete.
-
Storing respirators and other PPE properly in a way to protect them from damage, contamination, and, where applicable, deformation of the facepiece and exhalation valve.
-
Keeping required records of work-related fatalities, injuries, and illness.
-
-
OSHA is also providing upated guidance for Holiday Workplace Safety. There is guidance for those in Retail Sales, for Delivery, and for Order Fulfillment.
-
This winter season, protect yourself and your family from fraudulent flu or antiviral products. Like with COVID-19, there are no legally marketed over-the-counter drugs to prevent to prevent, mitigate, treat, or cure the flu. The FDA advises that the flu vaccine is the best prevention against the influenza and its serious complications.
-
China continues to report the presence of coronavirus on imported food products and packagingof shrimp, fish, beef, and pork. However, guidance from World Health Organization and other organizations continue to indicate that it is highly unlikely that people can contract COVID-19 from food or food packaging. Read the news from Food Safety News.
-
In Case You Missed It:
-
In last Friday’s Recommendations for Industry we explored testing and When and What COVID Tests Facilities Should Conduct.
-
Also last week:
-
OSHA has released new infographic guidance for “COVID-19 Guidance on Ventilation in the Workplace” [English] [Spanish], much of which follows that which TAG has previously discussed and encouraged.
-
CDC MMWR highlighted the protective measures of working from home, stating, “adults who received positive test results for SARS-CoV-2 infection were more likely to report exclusively going to an office or school setting in the 2 weeks before illness onset.” This highlights the importance, even now, of promoting alternative work site options where possible. Where not feasible, worker safety measures should continue to be scaled up.
-
A CDC publication “How to Protect Yourself & Others” stated that “older adults and people who have certain underlying conditions like heart or lung disease or diabetes are at increased risk of severe illness from COVID-19 illness.” This emphasizes the crucial need to continue to practice good personal hygiene, avoid close contact, wear a mask, clean and disinfect, monitor your health daily, and get a flu vaccine.
-
For a quick reference to identify if you might have COVID-19, the flu, the cold, or allergies, check out our recent infographic.
-
CDC has released new guidance for Celebrating Thanksgiving safely (to limit the spread of COVID-19 and the flu), noting that the safest way to celebrate Thanksgiving this year is to do so with people in your household. If you are celebrating with others outside your household, take steps like wearing a mask, staying socially distant, and washing your hands; consider celebrating outdoors, if not possible, open windows; and limit the number of guests and number of food-preparation individuals.
-
-
November 18, 2020
-
In today’s Recommendations for Industry, we explore the TAG’s U.S. Risk Matrix. This week, all states except for Hawaii (and D.C.) have moved to into the High or Highest-Risk Quadrants. Twenty-seven (27) states have a TPR greater than 10% and a case rate ≥ 25/100K, indicating that testing may not be adequate to characterize the true severity of outbreaks across the U.S fully.
-
Join our own Dr. Ben Miller, MPH with CIC Health and the University of Minnesota's Genomics Center on a webinar this Friday (November 20) at 12:00 PM E.T. as they discuss COVID-19 testing on campus, including how surveillance testing can help bridge the gap between now and widespread vaccination programs. Register here: https://link.achesongroup.com/0fdb2
-
Be Antibiotics Aware. November 18 – 24th is Antimicrobial Awareness Week. Antimicrobial resistance (which includes antibiotic resistance) is a significant threat to both human health and sustainable food production. Drug resistance has made infections harder to treat; however, good hygiene can help stop the spread of infection (especially during the COVID-19 pandemic). Find out more about the effects antimicrobial resistance has on food, health, and more.
-
As a reminder, a mask is not a substitute for social distancing (maintain 6 feet or more from others around you). Masks should still be worn in addition to staying at least 6 feet (2 meters) apart.
-
The “COVID-19 Symptoms Comparison Chart” is now downloadable at our COVID-19 Resources page.
-
Did you miss the October’s FSMA Friday in which TAG’s own Eric Edmunds discussed DA’s proposed Food Traceability Rule, the affected foods and ingredients on its Food Traceability List (FTL) and the rule’s foundational elements: Critical Tracking Events (CTEs) and Key Data Elements (KDEs), along with other key elements of the rule? Find the main points and recording here.
-
In Case You Missed It:
-
On Monday, we discussed and answered the question: How Risky is International – and Domestic – Travel Today?
-
In last Friday’s Recommendations for Industry we explored testing and When and What COVID Tests Facilities Should Conduct.
-
OSHA and the U.S. Department of Labor have issued Guidance Alerting Employers to Frequently Cited Standards Related to COVID-19 Inspections. The most frequently cited standards and requirements for employers to follow include:
-
Providing a medical evaluation before a worker is fit-tested or uses a respirator.
-
Establishing, implementing, and updating a written respiratory protection program with required worksite-specific procedures.
-
Training workers to safely use respirators and/or other PPE in the workplace, and retrain workers about changes in the workplace that might make previous training obsolete.
-
Storing respirators and other PPE properly in a way to protect them from damage, contamination, and, where applicable, deformation of the facepiece and exhalation valve.
-
Keeping required records of work-related fatalities, injuries, and illness.
-
-
OSHA is also providing upated guidance for Holiday Workplace Safety. There is guidance for those in Retail Sales, for Delivery, and for Order Fulfillment.
-
This winter season, protect yourself and your family from fraudulent flu or antiviral products. Like with COVID-19, there are no legally marketed over-the-counter drugs to prevent to prevent, mitigate, treat, or cure the flu. The FDA advises that the flu vaccine is the best prevention against the influenza and its serious complications.
-
China continues to report the presence of coronavirus on imported food products and packagingof shrimp, fish, beef, and pork. However, guidance from World Health Organization and other organizations continue to indicate that it is highly unlikely that people can contract COVID-19 from food or food packaging. Read the news from Food Safety News.
November 13, 2020
-
In today’s Recommendations for Industry, we explore testing and When and What COVID Tests Facilities Should Conduct
-
In Case You Missed It:
-
In Monday’s Recommendations for Industry, we discussed if a vaccine is coming soon and what you should know in the meantime.
-
In Wednesday’s, we explored TAG’s U.S. Risk Matrix. Forty-four (44) states are in the Highest-Risk Quadrant. Twenty-four (24) states have a TPR greater than 10% and a case rate ≥25/100K people indicates testing may not be adequate to fully characterize the true severity of the outbreak in these states.
-
Last Friday’s discussed the similarities and differences between COVID-19, the flu, the common cold, and allergies in a chart form!
-
This will be available for online download soon. However, if you want a copy now, please email Lily Yang ([email protected]).
-
-
OSHA has released new infographic guidance for “COVID-19 Guidance on Ventilation in the Workplace” [English] [Spanish]. Much of this guidance is parallel to what TAG has previously discussed and encouraged.
-
A recent CDC MMWR highlights the protective measures of working from home rather than onsite. In fact, “adults who received positive test results for SARS-CoV-2 infection were more likely to report exclusively going to an office or school setting in the 2 weeks before illness onset.” This is compared to those who tested negative, even among those working in a profession outside of the critical infrastructure. These findings highlight the importance, even now, of “promot[ing] alternative work site options, such as teleworking, where possible, to reduce exposures to SARS-CoV-2. Where telework options are not feasible, worker safety measures should continue to be scaled up to reduce possible worksite exposures.”
-
The recent CDC highlight for “How to Protect Yourself & Others” highlights that “older adults and people who have certain underlying conditions like heart or lung disease or diabetes are at increased risk of severe illness from COVID-19 illness.” This emphasizes the crucial need to continue to practice good personal hygiene, avoid close contact, wearing a mask over your nose and mouth when around others, clean and disinfect, and monitor your health daily.
-
Additionally, protect your health by getting a flu vaccine!
-
For a quick reference to identify if you might have COVID-19, the flu, the cold, or allergies, check out our recent infographic.
-
-
CDC has released new guidance for Celebrating Thanksgiving safely (to limit the spread of COVID-19 and the flu). As the holiday approaches, it is imperative to keep your business and workers safe.
-
Due to rising COVID-19 cases, the safest way to celebrate Thanksgiving this year is to do so with people in your household. Consider hosting a virtual Thanksgiving for those who do not live with you! Or prepare traditional dishes and deliver the food to others in a way that does not involve contact with others.
-
If you are celebrating with others outside your household, take steps like wearing a mask, staying socially distant from others, and washing your hands.
-
Consider celebrating outdoors (if possible), or if celebrating indoors, make sure to open windows.
-
Limit the number of guests you have, as well as the number of food-preparation individuals.
-
-
November 11, 2020
-
In today’s Recommendations for Industry, we explore TAG’s U.S. Risk Matrix. 44 states are in the Highest-Risk Quadrant. Twenty-four (24) states have a TPR greater than 10% and a case rate ≥ 25/100K people indicates testing may not be adequate to fully characterize the true severity of the outbreak in these states!
-
Tomorrow, Thursday November 12, the FDA is hosting a presentation to provide an overview of FDA’s research to evaluate the ability of facial coverings to reduce the spread of COVID-19 infection and how the FDA is developing a comprehensive risk-assessment tool to predict the probability of infection with different types of masks. Register here.
-
Global cases of COVID-19 have exceeded 51 million cases.
-
U.S. hospital cases are rising.
-
-
The CDC’s recent highlight for “How to Protect Yourself & Others” highlights that “older adults and people who have certain underlying conditions like heart or lung disease or diabetes are at increased risk of severe illness from COVID-19 illness”. As such, it is crucial to practice good personal hygiene, avoid close contact, wearing a mask over your nose and mouth when around others, clean and disinfect, and monitor your health daily.
-
Additionally, protect your health this flu season by getting a flu vaccine!
-
For a quick reference to identify if you might have COVID-19, the flu, the cold, or allergies, check out our recent infographic.
-
-
The CDC has also released new guidance for Celebrating Thanksgiving safely (to limit the spread of COVID-19 and the flu). As the holiday approaches, it is imperative to keep your business and workers safe.
-
Due to rising COVID-19 cases, the safest way to celebrate Thanksgiving this year is to celebrate with people in your household. Consider hosting a virtual Thanksgiving for those who do not live with you! Or prepare traditional dishes and deliver the food to others in a way that does not involve contact with others.
-
If you are celebrating with others outside your household, take steps like wearing a mask, staying socially distant from others, and washing your hands.
-
Consider celebrating outdoors (if possible), or if celebrating indoors, “make sure to open windows”.
-
Limit the number of guests you have; additionally, limit the number of food-preparation individuals.
-
Get your flu shot!
-
-
In Case You Missed It:
-
In Monday’s Recommendations for Industry, we discuss if a vaccine is coming soon and what you should know in the meantime!
-
On Friday’s Recommendations for Industry, we discuss the similarities and differences between COVID-19, the flu, the common cold, and allergies in a chart form!
-
This will be available for online download soon. However, if you want a copy now, please email Lily Yang ([email protected]).
-
-
Global cases of COVID-19, on Monday, exceeded 50 million cases.
-
OSHA has released new infographic guidance for “COVID-19 Guidance on Ventilation in the Workplace” [English] [Spanish]. Much of this guidance is parallel to what TAG has discussed previously and encouraged.
-
A recent CDC MMWR highlights teleworking's protective measures (or working from home) and not onsite. In fact, “adults who received positive test results for SARS-CoV-2 infection were more likely to report exclusively going to an office or school setting in the 2 weeks before illness onset.” This is compared to those who tested negative, even among those working in a profession outside of the critical infrastructure. These findings highlight the importance, even now, of “promot[ing] alternative work site options, such as teleworking, where possible, to reduce exposures to SARS-CoV-2. Where telework options are not feasible, worker safety measures should continue to be scaled up to reduce possible worksite exposures.”
-
November 09, 2020
-
In today’s Recommendations for Industry, we discuss if a vaccine is coming soon and what you should know in the meantime!
-
Global cases of COVID-19 have exceed 50 million cases.
-
OSHA has released a new infographic guidance for “COVID-19 Guidance on Ventilation in the Workplace” [English] [Spanish]. Much of this guidance is parallel to what TAG has discussed previously and encouraged.
-
A recent CDC MMWR highlights teleworking's protective measures (or working from home) and not onsite. In fact, “adults who received positive test results for SARS-CoV-2 infection were more likely to report exclusively going to an office or school setting in the 2 weeks before illness onset.” This is compared to those who tested negative, even among those working in a profession outside of the critical infrastructure. These findings highlight the importance, even now, of “promot[ing] alternative work site options, such as teleworking, where possible, to reduce exposures to SARS-CoV-2. Where telework options are not feasible, worker safety measures should continue to be scaled up to reduce possible worksite exposures.”
-
In Case You Missed It:
-
On Friday’s Recommendations for Industry, we discuss the similarities and differences between COVID-19, the flu, the common cold, and allergies in a chart form!
-
This will be available for online download, soon. However, if you want a copy now, please email Lily Yang ([email protected]).
-
-
Last Monday, in Recommendations for Industry we answered questions on asymptomatic COVID-19 cases and what that might mean. Read more here.
-
If your household includes one or more vulnerable individuals, then all family members should act as if they, themselves, are at a higher risk. Learn more about protecting yourself and your family, especially when you live in close quarters, including limiting errands, keeping vulnerable members from caring for children and those who are ill, separating a sick household member, etc.
-
As states are slowly re-opening dine-in services in restaurants, OSHA has released Guidance for Restaurants to protect their businesses, their employees, and their customers. Find the downloadable infographic in English (link) and Spanish (link).
-
Did you miss Dr. Ben Miller’s discussion on utilizing Assurance Testing as part of your COVID-19 preventive protocols? Catch the recorded webinar on Youtube, here.
-
If you have been wondering what’s happening with vaccines, TAG will be putting out a short perspective on this soon. For a longer, comprehensive run-down on vaccines' current status, the New York Times has provided a thorough interactive summary.
-